Pathstone Holdings’s LeonaBio Inc LONA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-38,606
Closed -$279K 2236
2025
Q4
$279K Hold
38,606
﹤0.01% 1994
2025
Q3
$160K Buy
38,606
+1,386
+4% +$5.44K ﹤0.01% 2231
2025
Q2
$112K Hold
37,220
﹤0.01% 2106
2025
Q1
$106K Hold
37,220
﹤0.01% 2140
2024
Q4
$218K Sell
37,220
-11,993
-24% -$67.7K ﹤0.01% 2130
2024
Q3
$219K Sell
49,213
-10
-0% -$235 ﹤0.01% 2126
2024
Q2
$1.3M Hold
49,223
0.01% 1170
2024
Q1
$1.35M Buy
49,223
+11,993
+32% +$380K 0.01% 1105
2023
Q4
$905K Buy
+37,230
New +$660K ﹤0.01% 1135

Other funds holding LONA

Pathstone Holdings's LONA Position: Q1 2026 in Review

Pathstone Holdings sold out of LeonaBio Inc (LONA) in Q1 2026, closing a stake of 38,606 shares — an estimated $279K sold.

Pathstone Holdings first reported a position in LONA in Q4 2023 and held it in 9 quarters. The position peaked at $1.35M in Q1 2024. 40 funds tracked by Wall St. Rank hold LONA as of Q1 2026.

  • Pathstone Holdings reported no remaining LeonaBio Inc position as of Q1 2026 after selling out during the quarter.
  • Pathstone Holdings sold 38,606 LeonaBio Inc shares in Q1 2026, an estimated $279K.
  • Pathstone Holdings first reported a position in LeonaBio Inc in Q4 2023 and held it in 9 quarters.
  • Pathstone Holdings's LeonaBio Inc position peaked at $1.35M in Q1 2024.
  • 40 funds tracked by Wall St. Rank held LeonaBio Inc as of Q1 2026.

Based on Pathstone Holdings's 13F filing for Q1 2026, filed 11 May 2026.